+386.3%
FCX vs SBAC
+103.9%
+282.4%
-72.6%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 10y.
| Period | Portfolio | SBAC | Excess | Alpha |
|---|---|---|---|---|
| 1D | -3.2% | +0.6% | -3.8% | -3.4% |
| 7D | -2.4% | +3.6% | -6.0% | -3.4% |
| 30D | -18.0% | +4.9% | -22.9% | -19.2% |
| 3M | -14.3% | +6.5% | -20.7% | -16.0% |
| 6M | -1.7% | -11.1% | +9.4% | +0.6% |
| YTD | +19.8% | +0.9% | +18.9% | +16.7% |
| 1Y | +48.6% | -1.6% | +50.2% | +45.9% |
| 3Y | +85.8% | -7.0% | +92.8% | +81.3% |
| 5Y | +72.2% | -39.2% | +111.5% | +93.1% |
| 10Y | +386.3% | +111.4% | +274.9% | +423.1% |
| All | +386.3% | +103.9% | +282.4% | +423.1% |
Cumulative growth
Daily Returns
Daily percentage return beside SBAC.
Daily Out/Under-Performance
Portfolio return minus SBAC return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × SBAC return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 10y: compounded portfolio wealth divided by compounded SBAC wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
10y analysis · Full analysis span regression · 6 months rolling